Jilin Jian Yisheng Pharmaceutical Co., Ltd.

¥6.07As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002566Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (6.54%)
Div yield 1.32%
ROE 1.08%
Biotechnology
Beta (5Y) 0.28
PE TTM 76.93
TSR TTM (25.04%)
Mkt cap ¥2.009B
ROIC 1.44%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥6.33
4.32%
(43.52%)
Hold 10|12|7|5|7
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.13
0.15
0.15
0.17
6.09%
17.21%
24.46%
35.22%
Revenue¥M
91.79
89.37
88.25
90.36
2.86%
(4.91%)
(6.24%)
(3.30%)
Peers (US$301.1M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
3.515
(0.062)
(0.050)
EBIT/Intx
0.057
0.433
0.403
Own earn%
(275.42)
(22.33)
(22.44)
Sh yield%
27.34
23.58
19.82
Owners
Insiders/Inst%
6.92
46.38
Short interest%
4.77
SBC / revenue%
2.75
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
28–35
$1 testx
0.0
Incr. ROIC%
4